However, since even systemic candidiasis can be easily controlled with standard fungicide therapy (Supplementary Fig. S3), our data do not discourage the development and testing of LMP7-selective inhibitors as therapeutics against autoimmune diseases and inflammatory disorders. Here, PSMB8 is linked to candidiasis.